home > drugs a-z list > curosurf (poractant alfa) drug center

Curosurf

font size

Curosurf Drug Center

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Curosurf Prescribing Information: Indications & Dosage

CUROSURF (poractant alfa) is indicated for the treatment (rescue) of Respiratory Distress Syndrome (RDS) in premature infants. CUROSURF (poractant alfa) reduces mortality and pneumothoraces associated with RDS.

Read the complete drug monograph for Curosurf »

What is Curosurf Prescribing Information?

Drug Description - Indications & Dosage - Side Effects & Drug Interactions - Warnings & Precautions - Contraindications - Medication Guide and More

Related Resources for Curosurf

© Curosurf Patient Information is supplied by Cerner Multum, Inc. and Curosurf Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Additional Curosurf Information

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Privacy Policy

Women's Health

Find out what women really need.


From WebMD

Drugs and Treatment Resources
Featured Centers
Health Solutions From Our Sponsors